Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,106 public trials 2,040 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

NCT01399372

Conditions
Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Arizona Oncology-Deer Valley Center Phoenix, Arizona, United States
View all 45 locations
View Trial Details
Completed

Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology

NCT02847130

Conditions
Acute Lymphoblastic Leukemia, B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, +28 more
Locations
  • Kaiser Permanente-Oakland Oakland, California, United States
  • Alfred I duPont Hospital for Children Wilmington, Delaware, United States
  • Golisano Children's Hospital of Southwest Florida Fort Myers, Florida, United States
  • Memorial Regional Hospital/Joe DiMaggio Children's Hospital Hollywood, Florida, United States
View all 33 locations
View Trial Details
Completed

SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients

NCT01749969

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Investigational Site Number 840004 San Francisco, California, United States
  • Investigational Site Number 840001 Tampa, Florida, United States
  • Investigational Site Number 840002 St Louis, Missouri, United States
  • Investigational Site Number 840005 New York, United States
View Trial Details
Completed

A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL)

NCT04954326

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Regional Children Clinical Hospital Chelyabinsk, Russia
  • Children Regional Clinical Hospital Krasnodar, Russia
  • Russian Children Clinical Hospital Moscow, Russia
  • Regional Children Hospital Nizhny Novgorod, Russia
View Trial Details

Related conditions